NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease.

Autor: Berven H; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Pb 7804, 5020, Bergen, Norway.; K.G. Jebsen Center for Translational Research in Parkinson's disease, University of Bergen, Pb 7804, 5020, Bergen, Norway., Kverneng S; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Pb 7804, 5020, Bergen, Norway.; K.G. Jebsen Center for Translational Research in Parkinson's disease, University of Bergen, Pb 7804, 5020, Bergen, Norway., Sheard E; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway., Søgnen M; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway., Af Geijerstam SA; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway., Haugarvoll K; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway., Skeie GO; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Pb 7804, 5020, Bergen, Norway., Dölle C; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway. Christian.Doelle@uib.no.; Department of Clinical Medicine, University of Bergen, Pb 7804, 5020, Bergen, Norway. Christian.Doelle@uib.no.; K.G. Jebsen Center for Translational Research in Parkinson's disease, University of Bergen, Pb 7804, 5020, Bergen, Norway. Christian.Doelle@uib.no., Tzoulis C; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway. charalampos.tzoulis@uib.no.; Department of Clinical Medicine, University of Bergen, Pb 7804, 5020, Bergen, Norway. charalampos.tzoulis@uib.no.; K.G. Jebsen Center for Translational Research in Parkinson's disease, University of Bergen, Pb 7804, 5020, Bergen, Norway. charalampos.tzoulis@uib.no.

Publikováno v: Nature communications [Nat Commun] 2023 Nov 28; Vol. 14 (1), pp. 7793. Date of Electronic Publication: 2023 Nov 28.